Several reports have demonstrated the beneficial effects conferred by Nrf2 activation against drug-induced kidney injury [10,11,12,13], whereas its deficiency augmented AKI induced by ischemia or nephrotoxic drugs [14]. This evidence concerns the gene NFE2L2 and acute kidney injury.